Clinical Trial Update: Understanding the Immune Response to Meningitis Vaccines [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update from the University of Oxford examines the immune response to meningitis vaccines. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Sepsis

Drugs mentioned

• Meningitis vaccine (study)

Snippet

Sponsor: University of Oxford | Conditions: Meningitis, Septicemia | Phase 3 | Status: COMPLETED